Industry: Service & Software
Published Date: 2025-02-07
Pages: 131 Pages
Report ld: 3669743
Request Sample
Customized Report
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Cell Immortalization was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Immortalization was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Cell Immortalization was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Cell Immortalization include GeneCopoeia, Lonza, Thermo Fisher Scientific, JSR, Valneva, Sartorius, Merck, Applied Biological Materials Inc., InSCREENeX GmbH, BioCat GmbH, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Immortalization, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell Immortalization by region & country, by Type, and by Application.
The Cell Immortalization market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Immortalization.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell Immortalization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell Immortalization in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell Immortalization in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell Immortalization Product Introduction
1.2 Global Cell Immortalization Market Size Forecast (2020-2031)
1.3 Cell Immortalization Market Trends & Drivers
1.3.1 Cell Immortalization Industry Trends
1.3.2 Cell Immortalization Market Drivers & Opportunity
1.3.3 Cell Immortalization Market Challenges
1.3.4 Cell Immortalization Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell Immortalization Players Revenue Ranking (2024)
2.2 Global Cell Immortalization Revenue by Company (2020-2025)
2.3 Key Companies Cell Immortalization Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell Immortalization Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell Immortalization
2.6 Cell Immortalization Market Competitive Analysis
2.6.1 Cell Immortalization Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Cell Immortalization Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Immortalization as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stem Cell Therapy
3.1.2 Cell Transplantation
3.1.3 Drug Transport
3.1.4 Others
3.2 Global Cell Immortalization Sales Value by Type
3.2.1 Global Cell Immortalization Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cell Immortalization Sales Value, by Type (2020-2031)
3.2.3 Global Cell Immortalization Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biopharmaceutical Company
4.1.2 Research Laboratory
4.1.3 Hospital
4.1.4 Other
4.2 Global Cell Immortalization Sales Value by Application
4.2.1 Global Cell Immortalization Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cell Immortalization Sales Value, by Application (2020-2031)
4.2.3 Global Cell Immortalization Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Cell Immortalization Sales Value by Region
5.1.1 Global Cell Immortalization Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cell Immortalization Sales Value by Region (2020-2025)
5.1.3 Global Cell Immortalization Sales Value by Region (2026-2031)
5.1.4 Global Cell Immortalization Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Cell Immortalization Sales Value, 2020-2031
5.2.2 North America Cell Immortalization Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Cell Immortalization Sales Value, 2020-2031
5.3.2 Europe Cell Immortalization Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Cell Immortalization Sales Value, 2020-2031
5.4.2 Asia Pacific Cell Immortalization Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Cell Immortalization Sales Value, 2020-2031
5.5.2 South America Cell Immortalization Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell Immortalization Sales Value, 2020-2031
5.6.2 Middle East & Africa Cell Immortalization Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell Immortalization Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cell Immortalization Sales Value, 2020-2031
6.3 United States
6.3.1 United States Cell Immortalization Sales Value, 2020-2031
6.3.2 United States Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cell Immortalization Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cell Immortalization Sales Value, 2020-2031
6.4.2 Europe Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cell Immortalization Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cell Immortalization Sales Value, 2020-2031
6.5.2 China Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cell Immortalization Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cell Immortalization Sales Value, 2020-2031
6.6.2 Japan Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cell Immortalization Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cell Immortalization Sales Value, 2020-2031
6.7.2 South Korea Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cell Immortalization Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cell Immortalization Sales Value, 2020-2031
6.8.2 Southeast Asia Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cell Immortalization Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cell Immortalization Sales Value, 2020-2031
6.9.2 India Cell Immortalization Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cell Immortalization Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GeneCopoeia
7.1.1 GeneCopoeia Profile
7.1.2 GeneCopoeia Main Business
7.1.3 GeneCopoeia Cell Immortalization Products, Services and Solutions
7.1.4 GeneCopoeia Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.1.5 GeneCopoeia Recent Developments
7.2 Lonza
7.2.1 Lonza Profile
7.2.2 Lonza Main Business
7.2.3 Lonza Cell Immortalization Products, Services and Solutions
7.2.4 Lonza Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.2.5 Lonza Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Profile
7.3.2 Thermo Fisher Scientific Main Business
7.3.3 Thermo Fisher Scientific Cell Immortalization Products, Services and Solutions
7.3.4 Thermo Fisher Scientific Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 JSR
7.4.1 JSR Profile
7.4.2 JSR Main Business
7.4.3 JSR Cell Immortalization Products, Services and Solutions
7.4.4 JSR Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.4.5 JSR Recent Developments
7.5 Valneva
7.5.1 Valneva Profile
7.5.2 Valneva Main Business
7.5.3 Valneva Cell Immortalization Products, Services and Solutions
7.5.4 Valneva Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.5.5 Valneva Recent Developments
7.6 Sartorius
7.6.1 Sartorius Profile
7.6.2 Sartorius Main Business
7.6.3 Sartorius Cell Immortalization Products, Services and Solutions
7.6.4 Sartorius Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.6.5 Sartorius Recent Developments
7.7 Merck
7.7.1 Merck Profile
7.7.2 Merck Main Business
7.7.3 Merck Cell Immortalization Products, Services and Solutions
7.7.4 Merck Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.7.5 Merck Recent Developments
7.8 Applied Biological Materials Inc.
7.8.1 Applied Biological Materials Inc. Profile
7.8.2 Applied Biological Materials Inc. Main Business
7.8.3 Applied Biological Materials Inc. Cell Immortalization Products, Services and Solutions
7.8.4 Applied Biological Materials Inc. Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.8.5 Applied Biological Materials Inc. Recent Developments
7.9 InSCREENeX GmbH
7.9.1 InSCREENeX GmbH Profile
7.9.2 InSCREENeX GmbH Main Business
7.9.3 InSCREENeX GmbH Cell Immortalization Products, Services and Solutions
7.9.4 InSCREENeX GmbH Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.9.5 InSCREENeX GmbH Recent Developments
7.10 BioCat GmbH
7.10.1 BioCat GmbH Profile
7.10.2 BioCat GmbH Main Business
7.10.3 BioCat GmbH Cell Immortalization Products, Services and Solutions
7.10.4 BioCat GmbH Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.10.5 BioCat GmbH Recent Developments
7.11 Creative Biolabs
7.11.1 Creative Biolabs Profile
7.11.2 Creative Biolabs Main Business
7.11.3 Creative Biolabs Cell Immortalization Products, Services and Solutions
7.11.4 Creative Biolabs Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.11.5 Creative Biolabs Recent Developments
7.12 GenScript
7.12.1 GenScript Profile
7.12.2 GenScript Main Business
7.12.3 GenScript Cell Immortalization Products, Services and Solutions
7.12.4 GenScript Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.12.5 GenScript Recent Developments
7.13 Nucleus Biotech
7.13.1 Nucleus Biotech Profile
7.13.2 Nucleus Biotech Main Business
7.13.3 Nucleus Biotech Cell Immortalization Products, Services and Solutions
7.13.4 Nucleus Biotech Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.13.5 Nucleus Biotech Recent Developments
7.14 ALSTEM
7.14.1 ALSTEM Profile
7.14.2 ALSTEM Main Business
7.14.3 ALSTEM Cell Immortalization Products, Services and Solutions
7.14.4 ALSTEM Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.14.5 ALSTEM Recent Developments
7.15 Maxanim
7.15.1 Maxanim Profile
7.15.2 Maxanim Main Business
7.15.3 Maxanim Cell Immortalization Products, Services and Solutions
7.15.4 Maxanim Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.15.5 Maxanim Recent Developments
7.16 Bio-REV Singapore
7.16.1 Bio-REV Singapore Profile
7.16.2 Bio-REV Singapore Main Business
7.16.3 Bio-REV Singapore Cell Immortalization Products, Services and Solutions
7.16.4 Bio-REV Singapore Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.16.5 Bio-REV Singapore Recent Developments
7.17 MilliporeSigma
7.17.1 MilliporeSigma Profile
7.17.2 MilliporeSigma Main Business
7.17.3 MilliporeSigma Cell Immortalization Products, Services and Solutions
7.17.4 MilliporeSigma Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.17.5 MilliporeSigma Recent Developments
7.18 AcceGen
7.18.1 AcceGen Profile
7.18.2 AcceGen Main Business
7.18.3 AcceGen Cell Immortalization Products, Services and Solutions
7.18.4 AcceGen Cell Immortalization Revenue (US$ Million) & (2020-2025)
7.18.5 AcceGen Recent Developments
8 Industry Chain Analysis
8.1 Cell Immortalization Industrial Chain
8.2 Cell Immortalization Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell Immortalization Sales Model
8.5.2 Sales Channel
8.5.3 Cell Immortalization Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 130
USD 3950.00
(Single User License)
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-04-30
Pages: 139
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-04-30
Pages: 159
USD 4900.00
(Single User License)
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 126
USD 2900.00
(Single User License)
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 107
USD 4250.00
(Single User License)
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 149
USD 4900.00
(Single User License)
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-26
Pages: 90
USD 2900.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 127
USD 3950.00
(Single User License)
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 130
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-04-30
Pages: 139
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-04-30
Pages: 159
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 126
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 107
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 149
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-26
Pages: 90
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 127
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now